IMV Inc.

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific & Clinical Advisors
  • Careers
    • Overview
    • Life at IMV
  • The DPX™ Platform
    • Overview
    • Scientific Publications & Posters
  • Clinical Pipeline
    • Overview
    • Maveropepimut-S
    • DPX-RSV
    • DPX-COVID-19
    • Clinical Trials
  • News & Events
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contact Us
    • FAQ
  • Contact

Press Releases

News & Events

News & Events

  • Press Releases
  • Events
  • Email Alerts
Apr 20, 2012 8:05am EDT

Immunovaccine Announces 2011 Year-End Results

Apr 13, 2012 9:07am EDT

Immunovaccine Inc. Named "Best Early-Stage Vaccine Biotech" at the 5th Vaccine Industry Excellence (ViE) Awards

Apr 03, 2012 2:02pm EDT

Immunovaccine Presents Findings of Cancer Vaccine Studies at AACR Meeting

Mar 12, 2012 8:48am EDT

Immunovaccine Joins with Weill Cornell Medical College to Advance Anti-Cocaine Vaccine

Mar 09, 2012 5:02pm EST

Immunovaccine Grants Stock Options

Feb 14, 2012 8:11am EST

Immunovaccine to Advance Biodefense Vaccines in a NIH Funded Study

Jan 05, 2012 9:30am EST

Immunovaccine to Present at Biotech Showcase 2012

Jan 04, 2012 9:15am EST

Immunovaccine Vaccinates First Patient in Phase I Trial of the DPX-Survivac Cancer Vaccine

Oct 17, 2011 8:07am EDT

Immunovaccine Appoints Wayne Pisano to its Board

Sep 23, 2011 5:30pm EDT

Immunovaccine Announces CEO Start Date, Grant of Options and Amendments to its Stock Option Plan

RSS
  • Prev
  • 1...
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • ...40
  • Next
IMV Inc.
About Us Careers The DPX™ Platform Clinical Pipeline News & Events Investors Contact
Twitter LinkedIn Youtube
© 2022 IMV Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap